Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial-Reference-Cited by-同舟云学术

Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial

Published:2017-04 Issue:4 Volume:197 Page:1014-1019
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Lewicki Patrick¹²,Shoag Jonathan¹²,Golombos David M.¹²,Oromendia Clara¹²,Ballman Karla V.¹²,Halpern Joshua A.¹²,Stone Benjamin V.¹²,O’Malley Padraic¹²,Barbieri Christopher E.¹²,Scherr Douglas S.¹²

Affiliation:

1. Department of Urology, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York

2. Department of Healthcare Policy and Research, Weill Cornell Medicine (CO, KVB), New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference26 articles.

1. Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach;Gann;J Clin Oncol,2010

2. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing;Bjurlin;J Urol,2013

3. Addressing the need for repeat prostate biopsy: new technology and approaches;Blute;Nat Rev Urol,2015

4. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer;Haider;AJR Am J Roentgenol,2007

5. Overdiagnosis and overtreatment of prostate cancer;Loeb;Eur Urol,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies;Diagnostics;2024-03-01

2. PIRADS ≥ 4 MRI lesion: Is performing systematic biopsies still essential for detecting clinically significant prostate cancer?;The French Journal of Urology;2024-03

3. Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsy;British Journal of Cancer;2023-10-28

4. Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome;Cancer Genomics - Proteomics;2023

5. Risk of progression following a negative biopsy in prostate cancer active surveillance;Prostate Cancer and Prostatic Diseases;2022-08-25